Companies/US/KZIA

KAZIA THERAPEUTICS LIMITED

Ownership & governance

Executives 5Directors 4Avg age 58Avg tenure 3.4y
John Friend
Chief Executive Officer
Age 56Since 2023-04-30Profile →

Shareholders5

NameStakeShares
Jorey Chernett
14.01 %
1,588,129
Lynwood Capital Management, Inc.
5.434 %
615,997
Ikarian Capital LLC
5.123 %
580,754
Bleichroeder LP
3.529 %
400,000
Stonepine Capital Management LLC
3.045 %
345,179

Catalog · 2026-07-09

Registry officers9

NameRoleSinceShares
James LevineDirector of Finance/CFO2026-05-31-
John FriendChief Executive Officer2023-04-30-
John FriendChairman2023-08-10-
Sudha RaoChief Tech/Sci/R&D Officer2026-04-14-
Ebru DavidsonDirector/Board Member2023-06-04-
Robert F. AppleDirector/Board Member2024-01-14-
Steven CoffeyDirector/Board Member2012-11-05-
Jeffrey KrawsCorporate Officer/Principal—-

Registry · as of 2026-07-09

Institutional (13F)

Loading Form 13F holders…

Fund membership

Loading fund baskets…

Street consensus

Consensus noneMean target 28.19Range 17.39–38.99Analysts 6
17.39Mean 28.1938.99
  • Strong buy 2
  • Buy 4

Broker actions19

FirmActionToTargetDate
BTIGReiteratedBuy402026-09-10
BTIGMaintainedBuy402026-09-01
Canaccord GenuityInitiatedBuy292026-08-13
BTIGReiteratedBuy342026-07-15
BTIGInitiatedBuy342026-07-01
Lake StreetInitiatedBuy322026-06-11
Laidlaw & Co.InitiatedBuy252026-04-15
HC Wainwright & Co.ReiteratedBuy182026-01-28
HC Wainwright & Co.MaintainedBuy182025-12-12
Maxim GroupMaintainedBuy202025-10-02
HC Wainwright & Co.MaintainedBuy132025-07-10
Maxim GroupMaintainedBuy152025-06-11

Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.

Peers